Singh Kern, Samartzis Dino, Strom James, Manning David, Campbell-Hupp Marion, Wetzel F Todd, Gupta Pernendu, Phillips Frank M
Department of Orthopaedic Surgery, Rush University Medical Center, Chicago, IL 60612, USA.
Spine (Phila Pa 1976). 2005 Nov 15;30(22):2477-83. doi: 10.1097/01.brs.0000186323.11285.b1.
Parallel design, prospective, double-blind, randomized, controlled trial composed of two independent groups treated with a continuous infusion catheter (saline vs. Marcaine) placed into the iliac crest bone graft (ICBG) site.
To determine the effects of postoperative continuous local anesthetic agent infusion at the ICBG harvest site in reducing pain, narcotic demand and usage, and improving early postoperative function after spinal fusion.
Harvesting iliac crest bone has been shown to be a source of pain and morbidity. Long-term patient complaints may be more closely associated with the procurement of the iliac crest graft rather than the primary surgical site.
Thirty-seven patients were enrolled in a prospective, randomized, double-blind parallel-designed study after informed consent and IRB approval was obtained. Twenty-eight patients had ICBG harvested for lumbar arthrodesis and nine for cervical arthrodesis. During spinal arthrodesis surgery, patients were randomly assigned to receive 96 mL (2 mL/hr x 48 hours) of either normal saline (control group, n = 22) or 0.5% Marcaine (treatment group, n = 15) delivered via a continuous infusion catheter placed at the ICBG harvest site. All patients received Dilaudid PCA after surgery. Pain scores, narcotic use/frequency, activity level, and length of stay (LOS) were recorded. Physicians, patients, nursing staff, and statisticians were blinded to the treatment.
Mean patient age was 60 years and similar between groups. Narcotic dosage, demand frequency, and mean VAS pain score were significantly less in the treatment (Marcaine) group at 24 and 48 hours (P < 0.05). The average LOS was 4.1 days with no difference between Marcaine or control groups. No complications were attributed to the infusion-catheter system.
Continuous infusion of 0.5% Marcaine at the ICBG harvest site reduced postoperative parenteral narcotic usage by 50% and decreased overall pain scores. No complications were attributed to the infusion-catheter system. The use of continuous local anesthetic infusion at the iliac crest may help in alleviating acute graft-related pain, hastening patient recovery and improving short-term satisfaction.
平行设计、前瞻性、双盲、随机对照试验,由两个独立组组成,分别通过置于髂嵴骨移植(ICBG)部位的连续输注导管给予生理盐水或布比卡因进行治疗。
确定在ICBG采集部位术后持续局部输注麻醉剂对减轻疼痛、减少麻醉剂需求和使用以及改善脊柱融合术后早期功能的效果。
已证明采集髂嵴骨是疼痛和发病的一个来源。患者的长期抱怨可能与髂嵴骨移植的获取而非主要手术部位关系更为密切。
在获得知情同意和机构审查委员会(IRB)批准后,37名患者被纳入一项前瞻性、随机、双盲平行设计研究。28名患者因腰椎融合术采集ICBG,9名患者因颈椎融合术采集ICBG。在脊柱融合手术期间,患者被随机分配通过置于ICBG采集部位的连续输注导管接受96毫升(2毫升/小时×48小时)的生理盐水(对照组,n = 22)或0.5%布比卡因(治疗组,n = 15)。所有患者术后均接受度冷丁自控镇痛。记录疼痛评分、麻醉剂使用/频率、活动水平和住院时间(LOS)。医生、患者、护理人员和统计人员对治疗情况均不知情。
患者平均年龄为60岁,两组间相似。在24小时和48小时时,治疗(布比卡因)组的麻醉剂剂量、需求频率和平均视觉模拟评分(VAS)疼痛评分显著更低(P < 0.05)。平均住院时间为4.1天,布比卡因组和对照组之间无差异。未发现与输注导管系统相关的并发症。
在ICBG采集部位持续输注0.5%布比卡因可使术后胃肠外麻醉剂使用减少50%,并降低总体疼痛评分。未发现与输注导管系统相关的并发症。在髂嵴处持续局部输注麻醉剂可能有助于减轻与移植相关的急性疼痛,加速患者康复并提高短期满意度。